Sustainable Plant‐Derived Polymeric Materials‐Based Nanocarriers for Targeted Drug Delivery of Breast Cancer Therapeutics: State‐of‐the‐Art Review
Open Access
- 31 August 2026
- journal article
- review article
- Published by Wiley in ChemistrySelect
- Vol. 11 (33) , e74002
Abstract
Globally, breast cancer is the most common cause of cancer‐related deaths in women. Despite considerable scientific advancements in drug design and discovery, the mortality rate has increased. However, finding precision breast cancer therapy and high‐efficiency anticancer drug delivery is still a considerable difficulty. A major challenge in cancer therapy is the lack of a highly selective drug‐delivery system that targets malignant cells without damaging healthy cells, thereby minimizing off‐target effects. Recently, novel drug delivery platforms based on plant‐derived polymeric materials have been rapidly developed, improving pharmacokinetic and therapeutic benefits for breast cancer treatment. Plant‐derived polymers can enable selective targeting, prolonged circulation, enhance drug delivery, and regulate cargo release through various methods with little or no toxicity. Polysaccharides, proteins, and gums are plant‐derived polymers that can self‐assemble and encapsulate both hydrophobic and hydrophilic chemotherapeutic agents. They can also protect drugs from harsh environmental conditions, such as ultraviolet light, enzymes, temperature fluctuations, gastric acid, and pH changes. The biomimetic and bio‐inspired, technology‐enabled, plant‐derived, polymer‐based nanocarriers hold promise for successful drug delivery and can help overcome these challenges. Furthermore, the surface modification of plant‐derived polymer‐based nanoparticles (NPs) enables them to respond to stimuli and deliver drugs efficiently. As a result, plant‐derived polymers are ideal nanocarriers for the targeted delivery of chemotherapies to treat breast cancer. This review summarizes recent developments in plant‐derived polymer‐based drug delivery systems for breast cancer therapy and discusses their future potential for designing safer, more effective anticancer treatments.Keywords
This publication has 160 references indexed in Scilit:
- The development of nanocarriers for natural productsWIREs Nanomedicine and Nanobiotechnology, 2024
- Hypoxia‐Responsive Tetrameric Supramolecular Polypeptide Nanoprodrugs for Combination TherapyAdvanced Healthcare Materials, 2023
- Synthesis of Magnetic Nanocarrier Conjugated by Folate Based on Tragacanth and In Vitro Investigation of their Efficiency on Breast Cancer CellsStarch - Stärke, 2023
- Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art reviewDrug Development Research, 2020
- Green approach for fabrication of chitosan‐neem gum polyelectrolyte stabilized penta and hexagonal nanoparticles and in‐vitro cytotoxic potential toward breast cancer (MCF‐7) cellsPrecision Medical Sciences, 2020
- Folate Receptor and Targeting Strategies2019
- Breast Cancer TreatmentJAMA, 2019
- Advances in Receptor‐Mediated, Tumor‐Targeted Drug DeliveryAdvanced Therapeutics, 2018
- Natural Polymer Drug Delivery Systems2016
- Development of wheat glutenin nanoparticles and their biodistribution in miceJournal of Biomedical Materials Research Part A, 2014